Ditchcarbon
  • Customers
  1. Organizations
  2. Cullinan Therapeutics, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 months ago

Cullinan Therapeutics, Inc.

Company website

Cullinan Therapeutics, Inc., a pioneering biopharmaceutical company headquartered in the United States, is dedicated to advancing innovative therapies for cancer treatment. Founded in 2018, Cullinan has rapidly established itself in the oncology sector, focusing on the development of targeted therapies that address unmet medical needs. With a robust pipeline of unique product candidates, Cullinan Therapeutics leverages its proprietary technology platforms to create differentiated treatments that enhance patient outcomes. The company’s commitment to scientific excellence and collaboration has positioned it as a notable player in the biopharmaceutical landscape, with significant achievements in clinical development and partnerships. As it continues to expand its operational reach, Cullinan Therapeutics remains at the forefront of transforming cancer care through cutting-edge research and development.

DitchCarbon Score

How does Cullinan Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Cullinan Therapeutics, Inc.'s score of 25 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.

30%

Let us know if this data was useful to you

Cullinan Therapeutics, Inc.'s reported carbon emissions

Cullinan Therapeutics, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi). As there are no emissions figures or reduction initiatives available, it is unclear how Cullinan Therapeutics, Inc. is addressing its carbon footprint or contributing to climate action within the biopharmaceutical industry. The lack of data suggests that the company may still be in the early stages of developing its climate strategy or reporting framework.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Cullinan Therapeutics, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Cullinan Therapeutics, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Cullinan Therapeutics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Johnson & Johnson Innovative Medicine

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Daiichi Sankyo

JP
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 4 days ago

Sandoz International GmbH

DE
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Spectrum Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Genzyme Corporation, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Genentech

US
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.10
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy